Inter-relationships between the severity of metabolic syndrome, insulin and adiponectin and their relationship to future type 2 diabetes and cardiovascular disease.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 27133621)

Published in Int J Obes (Lond) on May 02, 2016

Authors

M D DeBoer1, M J Gurka2, J A Morrison3,4, J G Woo4,5

Author Affiliations

1: Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
2: Department of Health Outcomes and Policy, University of Florida, Gainesville, FL, USA.
3: Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
4: Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
5: Division of Epidemiology and Biostatistics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Articles cited by this

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22

The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51

Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 15.48

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes (2009) 8.70

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation (2004) 7.77

Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet (1992) 6.28

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2009) 5.08

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care (2005) 4.38

Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr (2007) 3.45

Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation (2006) 2.89

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care (2006) 2.77

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation (2004) 2.65

What is the best predictor of future type 2 diabetes? Diabetes Care (2007) 2.64

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation (2007) 2.58

A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care (2003) 2.25

Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med (2008) 2.01

Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis (2010) 1.76

High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab (2008) 1.76

Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr (2009) 1.73

Insulin and risk of cardiovascular disease: a meta-analysis. Circulation (1998) 1.71

Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care (2012) 1.71

An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Metabolism (2013) 1.34

Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition (2012) 1.33

A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol (2012) 1.33

Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006. Metab Syndr Relat Disord (2010) 1.10

Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study. Diabetologia (2015) 1.06

Severity of Metabolic Syndrome as a Predictor of Cardiovascular Disease Between Childhood and Adulthood: The Princeton Lipid Research Cohort Study. J Am Coll Cardiol (2015) 1.04

Genetic architecture of lipid traits changes over time and differs by race: Princeton Lipid Follow-up Study. J Lipid Res (2014) 1.02

Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies. Obes Rev (2013) 0.96

Relationships of measurements of body mass to plasma lipoproteins in schoolchildren and adults. Am J Epidemiol (1980) 0.91

The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study. Atherosclerosis (2015) 0.89

Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later. J Pediatr (2010) 0.85

Hypoadiponectinemia in overweight children contributes to a negative metabolic risk profile 6 years later. Metabolism (2009) 0.82

Articles by these authors

Associations between birthweight and overweight and obesity in school-age children. Pediatr Obes (2017) 0.75